… Our results suggest that patients with higher aGAPSS, might be at higher risk for developing
extra-criteria manifestations of APS and should therefore undergo a thorough laboratory and …

… We will then highlight the recent progress in the risk assessment of APS patients as well
as asymptomatic aPL carriers in terms of future thrombotic and obstetric events and finally …

… Biomarkers that predict thrombosis risk in patients with antiphospholipid antibodies have
been … offer the best chance of identifying patients at highest risk of APS-related complications. …

… antibodies (aCL), and anti-β2-glycoprotein I antibodies (anti-β2GPI). aPL play a key pathogenic
role in the development of the antiphospholipid syndrome (… complications in patients with …

… Caring for APS patients remains a complex endeavour that requires individualised patient
risk assessment. Clinicians must recognise the limits of available evidence-based guidelines. …

… Data from 110 transplanted patients show that the presence of antiphospholipid antibodies
(aPL) … Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of …

… We carried out a meta-analysis of the risk of thrombosis associated with antiphospholipid
antibodies in … We could not assess the total number of patients with aCL and anti-β 2 GP-I …

… antiphospholipid syndrome. Obstetric care is based on combined medical-obstetric high-risk
management and … for non-pregnant patients with antiphospholipid syndrome are statins, …

… However, this meta-analysis deserves updating to include all … mechanisms of antiphospholipid
antibody syndrome (APS) … patients (presenting SLE or antiphospholipid syndrome [APS]…

… antiphospholipid antibodies (aPL) and different aPL profiles on the risk of thrombocytopenia
in SLE patients by conducting a systematic review and meta-analysis of available literature …